Sermorelin
Compoundable (Rx)Growth Hormone Secretagogues · GHRH Analog
Sermorelin is a synthetic analog of the first 29 amino acids of natural growth hormone-releasing hormone (GHRH).
What is Sermorelin?
Sermorelin is a synthetic analog of the first 29 amino acids of natural growth hormone-releasing hormone (GHRH). It was one of the first GHRH analogs to be FDA-approved (for pediatric GH deficiency) and remains widely used in anti-aging and hormone optimization clinics as a safer alternative to direct HGH therapy.
Also known as: GHRH(1-29)NH2, Geref
How Does Sermorelin Work?
Binds to GHRH receptors on somatotroph cells in the anterior pituitary, stimulating the synthesis and secretion of growth hormone in a natural pulsatile pattern. Preserves the hypothalamic-pituitary feedback loop, preventing excess GH production.
What is Sermorelin Used For?
- Growth hormone deficiency
- Anti-aging
- Sleep improvement
- Fat loss
- Muscle maintenance
Potential Side Effects
- Injection site reactions
- Flushing
- Headache
- Dizziness
- Hyperactivity
Contraindications
- Active malignancy
- Pregnancy
- Hypersensitivity to sermorelin
FDA Legal Status
United States — FDA
Compoundable (Rx)Related Peptides
CJC-1295
Compoundable (Rx)Growth Hormone Secretagogues
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates sustained growth hormone relea...
Ipamorelin
Compoundable (Rx)Growth Hormone Secretagogues
Ipamorelin is a selective growth hormone secretagogue that stimulates the pituitary gland to produce growth hormone with...
Tesamorelin
FDA ApprovedGrowth Hormone Secretagogues
Tesamorelin is an FDA-approved GHRH analog originally indicated for reducing excess abdominal fat in HIV-associated lipo...
Head-to-head comparisons:
Frequently Asked Questions
Is sermorelin the same as HGH?
Why take sermorelin at bedtime?
Quick Facts
- Legal Status (USA)
- Compoundable (Rx)
- Evidence Rating
- AStrong Evidence (Multiple RCTs)
- Class / Subclass
- Growth Hormone Secretagogues / GHRH Analog
- Administration
- subcutaneous
- Typical Dosage
- 200-300mcg daily at bedtime
- Half-Life
- ~10-20 minutes
- Brand Names
- Geref
- Year Discovered
- 1980
- Approval Year
- 1997
Sources
Last updated: 2026-04-01
Sources & references
Primary sources used for the dosing, mechanism, side-effect, and regulatory claims on this page. Verify time-sensitive information (regulatory status, prescribing details) on the source before relying on it for medical decisions. See our disclaimer.
- PubMed PMID 2190482 — peer-reviewed primary literature on Sermorelin.
- FDA Federal Register — official notice record for FDA regulatory actions and Category 1 / 503A bulk-substance updates.